Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.170

+6.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DrJerry who wrote (615)	11/10/1997 8:17:00 AM
From: Kip518	of 1605

Dr. Jerry, have you looked at this VEGF (VASCULAR ENDOTHELIAL CELL GROWTH FACTOR) research? I'm way over my head here. But from a scan of medical abstracts it looks like VEGF (and anti-VEGF) research has largely been directed at controlling the growth of cancer cells. But some of the recent work has turned to growing veins around block cardiac arteries. This seems to me to be VASO's domain. Assuming the VEGF therapy is approved (which could be a while as it appears they are still using mice & pigs), which would patients (& insurance companies) be more likely to want -- a pill or being cuffed into a machine for many sessions? That of course, does not consider relative costs differences between the two therapies, which might be huge! I'm a (very) long term holder of VASO and now that my faith in the company and product appears finally to be getting fulfilled, along comes this VEGF news. I'm concerned. No one else on this thread seems to be. What do you think? Thanks, Ron For examples, see: oup.co.uk oac.hsc.uth.tmc.edu bioscience.org (Or do a hotbot search on VEGF to find many more)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next